In contrast to the general population, ovarian cancer in BRCA mutation carriers is diagnosed at an earlier median age (54 and 59.5 years for the BRCA1 and BRCA2 mutations, respectively, vs. 63 years for wild-type BRCA) [8]. The gene discussed is BRCA1; the disease is ovarian carcinoma.